128 related articles for article (PubMed ID: 4412225)
21. Platelet aggregation: effects of cardiopulmonary bypass.
Solis RT; Beall AC; Noon GP; DeBakery ME
Chest; 1975 May; 67(5):558-63. PubMed ID: 1126194
[TBL] [Abstract][Full Text] [Related]
22. Comparison of bubble and membrane oxygenators in short and long perfusions.
Clark RE; Beauchamp RA; Magrath RA; Brooks JD; Ferguson TB; Weldon CS
J Thorac Cardiovasc Surg; 1979 Nov; 78(5):655-66. PubMed ID: 491720
[TBL] [Abstract][Full Text] [Related]
23. A comparison of pulmonary function in puppies undergoing total cardiopulmonary bypass with bubble or membrane oxygenators.
Rhodes EL; Kirsh MM; Howatt W; O'Rourke PT; Straker J; Sloan H
J Thorac Cardiovasc Surg; 1974 Oct; 68(4):658-63. PubMed ID: 4411602
[No Abstract] [Full Text] [Related]
24. Prolonged total left ventricular bypass in dogs.
Miller DR; Ashcraft W
Arch Surg; 1974 Feb; 108(2):195-200. PubMed ID: 4810527
[No Abstract] [Full Text] [Related]
25. Effects of oxygenator and pumping devices on blood parameters in open heart surgery: a clinical study.
Barlas S; Tireli E; Tekinalp H; Dayioğlu E; Sevgenay L; Barlas C
Adv Exp Med Biol; 1996; 388():617-23. PubMed ID: 8798867
[No Abstract] [Full Text] [Related]
26. Elimination of sevoflurane is reduced in plasma-tight compared to conventional membrane oxygenators.
Prasser C; Zelenka M; Gruber M; Philipp A; Keyser A; Wiesenack C
Eur J Anaesthesiol; 2008 Feb; 25(2):152-7. PubMed ID: 17655810
[TBL] [Abstract][Full Text] [Related]
27. Alterations of hemostasis associated with cardiopulmonary bypass.
Bick RL; Schmalhorst WR; Arbegast NR
Thromb Res; 1976 Mar; 8(3):285-302. PubMed ID: 131387
[No Abstract] [Full Text] [Related]
28. Total cardiopulmonary support with disposable membrane oxygenator during aortocoronary artery-vein graft operations.
Carlson RG; Landé AJ; Ivey LW; Starek PJ; Rees JR; Subramanian VA; Twichell J; Baxter J; Bloch JH; Lillehei CW
Chest; 1972 Oct; 62(4):424-32. PubMed ID: 4538671
[No Abstract] [Full Text] [Related]
29. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.
Rinder CS; Rinder HM; Smith BR; Fitch JC; Smith MJ; Tracey JB; Matis LA; Squinto SP; Rollins SA
J Clin Invest; 1995 Sep; 96(3):1564-72. PubMed ID: 7657827
[TBL] [Abstract][Full Text] [Related]
30. The effect of various filters on microembolic cerebrovascular blockade following cardiopulmonary bypass.
Patterson RH; Wasser JS; Porro RS
Ann Thorac Surg; 1974 May; 17(5):464-73. PubMed ID: 4132775
[No Abstract] [Full Text] [Related]
31. A comparison of the effects of membrane and bubble oxygenators on platelet counts and platelet size in elective cardiac operations.
Trumbull HR; Howe J; Mottl K; Nicoloff DM
Ann Thorac Surg; 1980 Jul; 30(1):52-7. PubMed ID: 7396579
[TBL] [Abstract][Full Text] [Related]
32. Platelet support for cardiopulmonary bypass surgery.
Harding SA; Shakoor MA; Grindon AJ
J Thorac Cardiovasc Surg; 1975 Aug; 70(2):350-3. PubMed ID: 1097840
[TBL] [Abstract][Full Text] [Related]
33. Effects of filler-free silicone rubber on platelets during bovine extracorporeal membrane oxygenation.
Yates WG; Schaap RN; Baumann GC
Trans Am Soc Artif Intern Organs; 1978; 24():644-9. PubMed ID: 716072
[No Abstract] [Full Text] [Related]
34. Use of membrane oxygenators without systemic heparinization for long-term partial bypass in dogs.
Hagler HK; Eberle JW; Watson JT; Platt MR; Sugg WL
Surg Forum; 1974; 25(0):130-1. PubMed ID: 4439140
[No Abstract] [Full Text] [Related]
35. [Platelet consumption and its prevention during cardiopulmonary bypass with a membrane oxygenator].
Kawada T; Funaki S; Hoson M; Masaki H; Ando N; Osada H; Okada T; Hiekata T; Noguchi T
Nihon Kyobu Geka Gakkai Zasshi; 1986 Sep; 34(9):1664-8. PubMed ID: 3794431
[No Abstract] [Full Text] [Related]
36. [Clinical assessment of complement activation and leukocyte kinetics during cardiopulmonary bypass: the effect of cepharanthine].
Masuda M; Tominaga R; Nokashima A; Mayumi H; Morita S; Kono H; Hisahara M; Fukae K; Miyamoto K; Kawachi Y
Kyobu Geka; 1993 Sep; 46(10):845-9. PubMed ID: 8377309
[TBL] [Abstract][Full Text] [Related]
37. Cardiopulmonary bypass. Microembolization and platelet aggregation.
Solis RT; Kennedy PS; Beall AC; Noon GP; DeBakey ME
Circulation; 1975 Jul; 52(1):103-8. PubMed ID: 1132112
[TBL] [Abstract][Full Text] [Related]
38. Disposable filter for microemboli in cardiopulmonary bypass. Clinical and histological findings.
Skagseth E; Froysaker T; Refsum SB
J Cardiovasc Surg (Torino); 1974; 15(3):318-22. PubMed ID: 4841244
[No Abstract] [Full Text] [Related]
39. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
Straub A; Wendel HP; Azevedo R; Ziemer G
Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
[TBL] [Abstract][Full Text] [Related]
40. Use of a capillary membrane oxygenator for total cardiopulmonary bypass in calves.
Kaye MP; Pace JB; Blatt SJ; Ferguson RJ
J Surg Res; 1973 Jan; 14(1):58-63. PubMed ID: 4691731
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
